David Melamed,  —

David earned a PhD in Biological Sciences from Columbia University in New York, NY, where he studied how Drosophila ovarian adult stem cells respond to cell signaling pathway manipulations. This work helped to redefine the organizational principles underlying adult stem cell growth models. He is currently a Science Writer, as part of the BioNews Services writing team.

Articles by

June 2, 2020 News by David Melamed

$1M Gene Therapy Research Grant Launched by PPMD, Duchenne UK

Parent Project Muscular Dystrophy (PPMD) and Duchenne UK have joined forces to offer up to $1 million in funding for gene therapy research in Duchenne muscular dystrophy (DMD). The organizations are specifically looking for proposals that address the immune system’s response to gene therapy, a major challenge…

Recent Posts